"10.1371_journal.pmed.1001290","plos medicine","2012-08-14T00:00:00Z","Thomas B Campbell; Laura M Smeaton; N Kumarasamy; Timothy Flanigan; Karin L Klingman; Cynthia Firnhaber; Beatriz Grinsztejn; Mina C Hosseinipour; Johnstone Kumwenda; Umesh Lalloo; Cynthia Riviere; Jorge Sanchez; Marineide Melo; Khuanchai Supparatpinyo; Srikanth Tripathy; Ana I Martinez; Apsara Nair; Ann Walawander; Laura Moran; Yun Chen; Wendy Snowden; James F Rooney; Jonathan Uy; Robert T Schooley; Victor De Gruttola; James Gita Hakim; PEARLS study team of the ACTG","Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, United States of America; Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts, United States of America; YRG Centre for AIDS Research & Education, Chennai, India; Brown Medical School, Providence, Rhode Island, United States of America; National Institutes of Health, Bethesda, Maryland, United States of America; Clinical HIV Research Unit, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Evandro Chagas Clinical Research Institute, Fiocruz, Rio de Janeiro, Brazil; Kamuzu Central Hospital, Lilongwe, Malawi; Department of Medicine, College of Medicine, Blantyre, Malawi; Nelson R. Mandela School of Medicine, Durban, South Africa; Institut Nacional de laboratoire et de Recherches, Port-au-Prince, Haiti; Asociación Civil Impacta Salud y Educación, Lima, Peru; Servico de Infectology, Hospital Nossa Senhora da Conceicao-GHC, Porto Alegre, Brazil; Department of Medicine and Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; National AIDS Research Institute, Pune, India; Frontier Science & Technology Research Foundation, Amherst, Massachusetts, United States of America; Social & Scientific Systems, Inc, Silver Spring, Maryland, United States of America; GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America; Gilead Sciences, Inc., Foster City, California, United States of America; Bristol-Myers Squibb Company, Plainsboro, New Jersey, United States of America; University of California San Diego, San Diego, United States of America; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe","¶ Membership of the AIDS Clinical Trials Group PEARLS Team is provided in the Acknowledgments.","TBC has received payments for lectures from, and served as a consultant for GlaxoSmithKline. TF has stock ownership in Abbot, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and has served as a consultant for Gilead Sciences. WS is an employee of GlaxoSmithKline. JFR is an employee and stockholder of Gilead Sciences. JU is an employee of Bristol-Myers Squibb. RTS has served as a consultant to GlaxoSmithKline, Gilead Sciences, Merck and Bristol-Myers Squibb. RTS has served as a member of Data and Safety Monitoring Boards for Gilead Sciences and had research contracts with Merck and Bristol-Myers Squibb. LMS, KLK, CF, BG, MCH, JK, UL, CR, JS, MM, KS, ST, AIM, AN, AW, LM, YC, VDG and JGH declare no conflicts of interest.","2012","08","Thomas B Campbell","TBC",27,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
